News
News
- Paratek Pharmaceuticals to Report Third Quarter 2020 Financial Results on November 5, 2020
10/27/2020 / 13:00 - GlobeNewswire - Paratek Pharmaceuticals Presenting New Data on NUZYRA® (Omadacycline) at IDWeek 2020
10/21/2020 / 14:00 - GlobeNewswire - Consortium of leading URW investors calls for REFOCUS, not RESET
10/15/2020 / 07:30 - GlobeNewswire - ASLAN Pharmaceuticals Completes Enrolment in Second Cohort and Opens New Sites in US and Australia in ASLAN004 Atopic Dermatitis Study
09/21/2020 / 12:00 - GlobeNewswire - Vectura Group plc - 2020 Interim Results
09/15/2020 / 13:00 - GlobeNewswire - ASLAN Pharmaceuticals to Present at H.C. Wainwright 22nd Annual Global Investment Conference
09/10/2020 / 09:08 - GlobeNewswire - Paratek Pharmaceuticals to Present at H.C. Wainwright 22nd Annual Global Investment Conference
09/09/2020 / 22:01 - GlobeNewswire - Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
09/01/2020 / 22:05 - GlobeNewswire - ASLAN Pharmaceuticals Resumes Recruitment of New Patients Into ASLAN004 Study
08/24/2020 / 09:27 - GlobeNewswire - Timber Pharmaceuticals Announces Appointment of Dr. David Cohen and Dr. Lubor Gaal to Board of Directors
08/19/2020 / 22:10 - GlobeNewswire
Real-time